Gustafson D L, Pritsos C A
Department of Nutrition, University of Nevada, Reno 89557.
Cancer Chemother Pharmacol. 1991;28(3):228-30. doi: 10.1007/BF00685517.
Mitomycin C (MMC) is a bioreductive alkylating agent that is capable of generating oxygen radicals. Porfiromycin (PM) is an analog to MMC that generates oxygen radicals at a significantly lower level than the parent compound. Under aerobic conditions, the toxicity of MMC to EMT6 cells is 2.5-fold that of PM, whereas hypoxically the two are equitoxic. In the present studies, the protective effect of PZ-51 in combination with NAC was assessed against the dose-dependent toxicity of either MMC or PM under both aerobic and hypoxic conditions. Aerobically, the PZ-51 and NAC combination inhibited the toxicity of MMC at concentrations of between 0.25 and 2 microM but had no effect on PM toxicity. Under hypoxic conditions, the PZ-51 and NAC combination had no effect on either MMC or PM toxicity. These findings support a role for oxygen radical generation in the aerobic toxicity of MMC at clinically relevant doses.
丝裂霉素C(MMC)是一种能产生氧自由基的生物还原烷基化剂。卟吩霉素(PM)是MMC的类似物,其产生氧自由基的水平明显低于母体化合物。在有氧条件下,MMC对EMT6细胞的毒性是PM的2.5倍,而在缺氧条件下两者毒性相当。在本研究中,评估了PZ - 51与N - 乙酰半胱氨酸(NAC)联合使用对MMC或PM在有氧和缺氧条件下剂量依赖性毒性的保护作用。在有氧条件下,PZ - 51与NAC联合使用在0.25至2微摩尔浓度时可抑制MMC的毒性,但对PM毒性无影响。在缺氧条件下,PZ - 51与NAC联合使用对MMC或PM毒性均无影响。这些发现支持了在临床相关剂量下,氧自由基生成在MMC有氧毒性中起作用。